| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
NGS testing for sarcomas
In-depth testing for an accurate diagnosis
Genetic fusions have been described in an increasing number of sarcoma types, making comprehensive testing a valuable diagnostic tool. In order to aid in the diagnosis of a wide range of tumors, our sarcoma NGS panel includes fusions in 138 individual genes. This analysis covers fusions described in 39 types of soft tissue, bone, and other mesenchymal tumors. Because fusion events can occur between known or novel gene partners, our NGS panel is designed to provide the most comprehensive analysis.
For a comprehensive list of sarcoma subtypes and gene fusions included in our NGS panel, see the additional resources section below.
39
subtypes assessed
138
genes evaluated
274
fusion variants detected
A Test in Focus
Andre Oliveira, M.D., Ph.D., gives an overview of the sarcoma NGS panel. He discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action can be taken due to the results of this testing.
Learn more about how to order this evaluation at your institution.
Additional resources
Five case studies that highlight several teaching points and walk through the testing ordered for each patient type
A comprehensive list of the tumor types and fusions associated that are included in our NGS panel
